Clinical Study on the Effectiveness and Safety of Pegylated Recombinant Human Granulocyte Stimulating Factor Injection and PEG-rhG-CSF in Mobilizing Autologous Hematopoietic Stem Cells in Lymphoma.
Latest Information Update: 04 May 2023
At a glance
- Drugs Pegfilgrastim (Primary)
- Indications Lymphoma
- Focus Therapeutic Use
- 04 May 2023 New trial record